BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31325200)

  • 21. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
    Meller S; Zipfel L; Gevensleben H; Dietrich J; Ellinger J; Majores M; Stein J; Sailer V; Jung M; Kristiansen G; Dietrich D
    Epigenetics; 2016 Dec; 11(12):871-880. PubMed ID: 27689475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
    Ushiku H; Yamashita K; Katoh H; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Watanabe M
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27629777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
    Yokoi K; Harada H; Yokota K; Ishii S; Tanaka T; Nishizawa N; Shimazu M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Feb; 26(2):406-414. PubMed ID: 30311169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.
    Ushiku H; Yamashita K; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Katoh H; Watanabe M
    Gastric Cancer; 2017 Sep; 20(5):784-792. PubMed ID: 28243814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
    Kojima K; Nakamura T; Ohbu M; Katoh H; Ooizumi Y; Igarashi K; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Yokota K; Kosaka Y; Sato T; Watanabe M; Yamashita K
    PLoS One; 2018; 13(5):e0194785. PubMed ID: 29746493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of endoscopic ultrasound in pancreatic cancer.
    Luz LP; Al-Haddad MA; Sey MS; DeWitt JM
    World J Gastroenterol; 2014 Jun; 20(24):7808-18. PubMed ID: 24976719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.
    Park JK; Lee JH; Noh DH; Park JK; Lee KT; Lee JK; Lee KH; Jang KT; Cho J
    Gut Liver; 2020 May; 14(3):387-394. PubMed ID: 31581388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
    Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study.
    Fulmer CG; Park K; Dilcher T; Ho M; Mirabelli S; Alperstein S; Hissong EM; Pittman M; Siddiqui M; Heymann JJ; Yantiss RK; Borczuk AC; Fernandes H; Sigel C; Song W; Mosquera JM; Rao R
    Cancer Cytopathol; 2020 Nov; 128(11):840-851. PubMed ID: 32598087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
    Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
    Kojima K; Nakamura T; Ooizumi Y; Igarashi K; Tanaka T; Yokoi K; Ishii S; Nishizawa N; Katoh H; Kosaka Y; Sato T; Watanabe M; Yamashita K
    PLoS One; 2019; 14(1):e0211108. PubMed ID: 30677088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.
    Brand RE; Adai AT; Centeno BA; Lee LS; Rateb G; Vignesh S; Menard C; Wiechowska-Kozłowska A; Bołdys H; Hartleb M; Sanders MK; Munding JB; Tannapfel A; Hahn SA; Stefańczyk L; Tsongalis GJ; Whitcomb DC; Conwell DL; Morisset JA; Gardner TB; Gordon SR; Suriawinata AA; Lloyd MB; Wylie D; Labourier E; Andruss BF; Szafranska-Schwarzbach AE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1717-23. PubMed ID: 24662333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
    Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
    J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A deep learning model using hyperspectral image for EUS-FNA cytology diagnosis in pancreatic ductal adenocarcinoma.
    Qin X; Zhang M; Zhou C; Ran T; Pan Y; Deng Y; Xie X; Zhang Y; Gong T; Zhang B; Zhang L; Wang Y; Li Q; Wang D; Gao L; Zou D
    Cancer Med; 2023 Aug; 12(16):17005-17017. PubMed ID: 37455599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoisolation of pancreatic epithelial cells from endoscopic ultrasound-guided fine needle aspirates with magnetic beads for downstream molecular application.
    Afify A; Huang EC; Jeong M; Urayama S
    Diagn Cytopathol; 2016 Jan; 44(1):32-8. PubMed ID: 26466823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma.
    Chiba M; Imazu H; Kato M; Ikeda K; Arakawa H; Kato T; Sumiyama K; Homma S
    Oncol Rep; 2017 Apr; 37(4):1943-1952. PubMed ID: 28260012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
    Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
    Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.